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Edited by Lukas HuberAbstract The protein transduction system has been employed
for delivery of bioactive proteins into cells via an endocytotic
mechanism. However, trapping of endocytosed proteins in the
endosome may signiﬁcantly attenuate biological actions in cells.
The present investigation demonstrated that endosomal release
of transduced protein could be artiﬁcially accelerated by
exposure to ﬂuorescent light. Exposure to light at 480 nm
stimulated endosomal release of transduced FITC-11 arginine-
protein transduction domain (11R-PTD), TAT-PTD and An-
tennapedia-PTD. Moreover, FITC-11R-p53 protein was
released from endosomes following stimulation with light. These
data suggest that photo-acceleration is a more eﬃcient strategy
in terms of the protein transduction system.
 2004 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Peptidic drugs and/or therapeutic proteins typically are
molecules characterized by small size consequent to limitations
associated with cell entry [1]. However, protein transduction
systems have been employed for delivery of full-length proteins
in rapid, concentration-dependent fashion into many cell types
[2–15]. A series of small domains, referred to as protein
transduction domains (PTDs, also known as cell-penetrating
peptides; CPPs), have been shown to cross biological mem-
branes eﬃciently and to promote the delivery of peptides and
proteins into cells. The Antennapedia homeodomain, a Dro-
sophila transcription factor, or its third helix, can deliver many
peptides, phosphopeptides and oligonucleotides into cells [2,3].
Similarly, TAT protein from human immunodeﬁciency virus
(HIV-1) is able to deliver biologically active proteins in vitro
and in vivo [4,5]; furthermore, VP22 protein from Herpes
simplex virus (HSV) also promotes delivery of covalently* Corresponding author. Fax: +81-86-235-7111.
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poly-lysine exhibit even greater eﬃciency in terms of delivery
of several peptides and proteins [8–12]. Studies by our group as
well as by others have demonstrated that these protein trans-
duction systems are eﬀective experimental and protein therapy
strategies [2–15].
Early investigations regarding the mechanism of internali-
zation by PTDs and PTD-fused proteins revealed that
internalization was not attenuated signiﬁcantly by incubation
at 4 C, by depletion of the cellular ATP pool or by inhibitors
of endocytosis, which indicated that internalization of PTD did
not involve endocytosis or speciﬁc protein transporters [16–18].
However, recent studies suggested that import and nuclear
localization of protein involving PTDs occurred during ﬁxa-
tion and not in living cells [19,20]. Other investigations indi-
cated that the majority of PTD uptake in living cells resulted
from initial rapid electrostatic interaction with the plasma
membrane followed by endocytotic uptake [21,22]. A recent
study clearly demonstrated that TAT-PTD was internalized by
lipid raft-dependent macropinocytosis [23]. However, a large
number of published reports documented PTD-mediated de-
livery of biologically active cargo, including proteins, peptides
and oligonucleotides. These studies suggested the occurrence of
partial endosomal release of these conjugates.
To improve endosomal escape, photochemical reactions are
initiated by photosensitization of compounds localized in
endocytic vesicles, inducing rupture of these vesicles upon light
exposure [24]. The present investigation documented the arti-
ﬁcial acceleration of endosomal release of transduced ﬂuores-
cence peptides and proteins by photo-excitation with respect to
the protein transduction system. This technique could provide
a more eﬃcient protein transduction strategy.2. Results
2.1. Transduction of PTDs by endocytosis
In order to examine the mechanism of internalization of
PTDs into living cells, cervix-derived HeLa cells were treated
with FITC-conjugated 11 arginine-PTD (11R-PTD), TAT-
PTD and/or Antennapedia-PTD (Antp-PTD) (green ﬂuores-
cence) with FM 4–64, an endocytotic marker (red ﬂuorescence).ation of European Biochemical Societies.
Fig. 1. Transduction of PTDs by endocytosis. HeLa cells were treated
with 1–10 lM FITC-conjugated 11R-PTD (a), TAT-PTD (b) and
Antp-PTD (c) (green ﬂuorescence; left panels) with FM 4–64, an ed-
ocytotic marker, (red ﬂuorescence; middle panels) for 30 min. The right
panels are overlays of these ﬁgures, i.e., the merger of both red and
green channels. Treated living cells were analyzed via confocal
microscopy.
Fig. 2. Photo-acceleration of release of transduced peptide from en-
dosomes. HeLa cells were treated with 1 lM FITC-conjugated 11R-
PTD for 30 min. Treated living cells were analyzed via confocal
microscopy. These cells were exposed to light at 480 nm for 30 s ex-
clusively in circled areas, followed by an additional 5-min incubation
(a). High-magniﬁcation with a DIC image of the same ﬁeld (b). Cells
within the circle exposed to light exhibited homogeneous ﬂuorescence
following the release of transduced peptide from endosomes.
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bution of the peptides was observed as a ﬂuorescent signal in
living unﬁxed HeLa cells (Fig. 1, left panels). PTDs predomi-
nantly co-localized with FM 4–64 in living cells as indicated by
the resultant yellow coloration of most punctuated vesicles
(Fig. 1, overlay). These data suggest that endocytosis plays a
major role in the uptake of PTDs.
2.2. Photo-acceleration of peptide release from endosomes
During these experiments, transduced peptide was artiﬁ-
cially released from endosomes upon stimulation with light
at 480 nm. Thirty minutes after treatment with PTDs,
punctuated cytoplasmic distribution of 11R-PTD (Fig. 2),
TAT-PTD and Antp-PTD (data not shown) was observed in
living cells. However, subsequent exposure of these cells to
light at 480 nm for 30 s, followed by an additional 5-min
incubation, led to dramatic alteration of the distribution of
PTDs. PTDs were released from endosomes; however, ho-
mogeneous distribution throughout the cells was evident
exclusively in areas exposed to light (Fig. 2(a) and (b)).
These data suggest that endosomal release of PTDs is ac-
celerated by photo-activation. To examine the cell toxicity of
this method, FITC-11R treated cells were exposed to light at
480 nm for 30 s. These cells were observed after 8 h in the
presence of propidium iodide (PI) (Fig. 2(c)). The cells did
not show the red ﬂuorescence. Taken together, these data
showed that photo acceleration of PTDs could be use
without cell toxicity.2.3. Real-time observation of peptide release
Peptide release from endosomes was observed in real-time.
HeLa cells were treated with 1–10 lM 11R-PTD, TAT-PTD
and Antp-PTD for 30 min. PTDs translocated across the
membrane due to endocytosis (Fig. 3(a)–(c), 0 min). Following
exposure to light at 480 nm, the ﬂuorescent peptide extended
markedly from endosomes; moreover, ﬂuorescence became
more evenly distributed in nuclei and cytoplasm (Fig. 3(a)–(c),
10 min and graphs). This enhanced release was not induced by
light at either 340 or 540 nm (Fig. 3(d)). Released FITC-pep-
tides in the cytosol exhibited much greater ﬂuorescent intensity
than those in endosomes. This enhancement of ﬂuorescent
intensity may reﬂect impaired ﬂuorescence of endosomally
trapped FITC-peptides as a consequence of the low pH envi-
ronment present within endosomes. In the primary neural
cells, punctuated appearance of transduced peptides was ob-
served initially, followed by alteration to a more homogeneous
Fig. 3. Real-time observation of endosomal peptide release in HeLa. HeLa cells were treated with 1–10 lM FITC-conjugated 11R-PTD (a), TAT-
PTD (b) and Antp-PTD (c) for 30 min; subsequently, cells were exposed continuously to light at 480 nm. Treated cells were analyzed every 5 s via
conventional ﬂuorescence microscopy. Fluorescent intensity (FI), which was measured with AquaCosmos software (Hamamatsu Photonics), is
presented for each ﬁeld. Eﬀect of several wavelengths on endosomal release (d). HeLa cells were treated with 1 lMFITC-conjugated 11R-PTD for 30
min and exposed to light at 340, 480 or 540 nm for 30 s. Treated cells were analyzed in real-time as noted above. Cells exhibiting normal morphology
were considered with respect to acquisition of ﬂuorescent intensity per cell; furthermore, analysis was performed utilizing the entire soma of indi-
vidual cells as the region of interest (ROI). The ﬂuorescent intensity of 10 Hela cells was counted; ﬁve sets of experiments were conducted. Back-
ground ﬂuorescent intensity was subtracted from all experiments. *P < 0:01.
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arrow, c and d). Uptake of PTDs was evident in the same areas
of the neuron (Fig. 4(c) and (d)). These data suggest the
presence of hot spots in terms of uptake of PTDs. The ﬂuo-
rescence in the whole cell body including the nucleus increasedconstantly following release from the endosome (Fig. 4(b)).
These ﬁndings suggest that light at 480 nm stimulates the ac-
celerated endosomal release of PTDs; furthermore, released
PTDs assume a homogeneous distribution in the cytoplasm
and the nucleus.
Fig. 4. Real-time observation of 11R-PTD release from endosomes in primary neural cells. Primary neural cells were treated with 1 lM FITC-
conjugated 11R-PTD for 30 min; subsequently, cells were exposed continuously to light at 480 nm. Treated cells were analyzed every 5 s via con-
ventional ﬂuorescence microscopy. Arrows indicate the occurrence of endocytosis of PTD; the PTD is released immediately (a). Nuclear ﬂuorescent
intensity (FI) (red circles) revealed a continuous increase in ﬂuorescence with time (b). High-magniﬁcation of the square in ﬁgure (a) is shown in (c).
Fluorescent intensity of the square area is presented in (d).
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functional peptides and protein
In order to determine whether peptides/proteins released
from endosomes operate as functional peptides, a nuclear lo-
calization signal was fused to the FITC-conjugated 11R (11R-
NLS). HeLa cells were treated with FITC-11R-NLS for 30
min, followed by exposure to light at 480 nm for 30 s. Photo-
exposed cells displayed nuclear localization of peptides relative
to the number observed prior to photo-stimulation (Fig. 5(a);
A and B). At higher magniﬁcation, ﬂuorescence is clearly lo-
calized in nuclei as well as in endosomal vesicles (Fig. 5(a); C).
These data suggest that transduced peptides released from
endosomes are not degraded; rather, these peptides remain
functional.
We next determined whether trapped protein release oc-
curred as a result of photo-exposure. Glioma cells were treated
with FITC-labeled 11R-p53 protein for 2 h, followed by ex-
posure to light at 480 nm for 30 s. The punctuated appearance
of transduced 11R-p53 was observed initially (Fig. 5(b); A),
followed by alteration to a more homogeneous distributionupon stimulation with light at 480 nm (Fig. 5(b); B). At high
magniﬁcation, predominant localization of p53 in the nucleus
was apparent in some cells (Fig. 5(b); C). Cells did not exhibit
red ﬂuorescence typical of propidium PI (Fig. 5(b); D). These
observations indicate that photo-acceleration of the protein
transduction system was suitable for proteins.3. Discussion
A number of studies, which employed this system for re-
porter proteins as well as for functional peptides and proteins
with PTDs, appear in the literature [2–5,7–15]. It is commonly
accepted that internalization of PTD, which occurs in a rapid,
ATP- and temperature-independent manner, does not involve
endocytosis or speciﬁc protein transporters [16–18]. Investi-
gation of the delivery of small peptide cargos by Antp-PTD
indicated that membrane shuttling occurred via the formation
of unilamellar phospholipid bubbles or inverted micelles [2].
However, inverted micelle formation requires the presence of
Fig. 5. (a) Eﬀect of light at 480 nm on PTD-fused functional peptides.
(A) HeLa cells were treated with 1 lM FITC-conjugated 11R-NLS
peptides for 30 min. The left side of the white line was exposed to light
at 480 nm for 30 s. Cells were visualized by confocal laser microscopy
and as a merger of ﬂuorescence and DIC (B). High-magniﬁcation of
light-exposed cells demonstrated ﬂuorescence in the nuclei following
peptide release from endosomes (C). (b) Glioma cells were treated with
1 lM FITC-conjugated 11R-p53 for 2 h; subsequently, cells were
washed with conventional fresh medium and visualized by confocal
laser microscopy (A). Then, cells were exposed to light at 480 nm for
30 s. Cells were visualized by confocal laser microscopy. After 2 h,
light-exposed cells demonstrated homogeneous ﬂuorescence in the
cytosol and nuclei following protein release from endosomes (B). At
higher magniﬁcation, the white arrow indicates nuclear localization of
p53 (C). These cells did not display PI staining (D).
M. Matsushita et al. / FEBS Letters 572 (2004) 221–226 225hydrophobic amino acids, which are absent in TAT-PTD and
11R-PTD. Additionally, cargo size is limited. These ﬁndings
suggest that this PTD delivery mechanism is improbable. Re-
cent studies demonstrated the involvement of cellular inter-
nalization of PTDs in endocytosis [21–23]. Therefore, it is
likely that the major mechanism of protein transduction in-
volves in endocytotic uptake and subsequent release from en-dosomes. The present data support the revised version of the
transduction mechanism.
Additionally, this investigation revealed that endosomal re-
lease can be accelerated under speciﬁc conditions, i.e., photo-
activation. The current study demonstrated accelerated release
of transduced FITC-PTDs from endosomes by stimulation
with light at 480 nm. These ﬁndings established a novel
method for delivery of a large variety of macromolecules and
small molecules, which are unable to enter the cytosol without
assistance.4. Materials and methods
4.1. Peptide synthesis
Peptides (11R-PTD; RRRRRRRRRRR, TAT-PTD; YGR-
KKRRQRRR, Antp-PTD; RQIKIWFQNRRMKWKK, and
11R-NLS; RRRRRRRRRRR-PKKKRKV) and ﬂuorescein-isothio-
cyanate- (FITC) conjugated peptides were synthesized by Sigma
Genosys, Japan. The peptides, which were puriﬁed by preparative re-
verse-phase HPLC, displayed >95% purity by HPLC. All peptides
exhibited the expected amino acid composition and mass spectra.
4.2. Protein labeling with FITC
11R-p53 was puriﬁed by Ni-NTA chromatography as previously
described [12]. The puriﬁed protein was labeled by coupling to FITC
(Molecular Probes).
4.3. Cell line and primary neural culture from rat brain
Cervix-derived HeLa cells and KR158 glioma cells were maintained
in DMEM (Gibco) supplemented with 10% fetal calf serum (FCS) and
penicillin-streptomycin (50 IU/ml and 50 lg/ml). The cells were plated
onto glass coverslips in 35-mm culture dishes. Dissociated neuronal
culture was prepared and maintained by a modiﬁed procedure as
previously described [8]. Cultures could be maintained in a healthy
condition for up to four weeks without medium change. Cultures at
9–14 days after plating were utilized in this study.
4.4. Treatment of FITC-PTDs and/or FM 4–64
Cells were incubated with 1–10 lM FITC-11R-PTD, TAT-PTD and
Antp-PTD and 10 lM FM 4–64 (Molecular Probes); subsequently,
cells were washed with the conventional medium. Treated cells were
analyzed with a confocal microscope in either the conventional or
confocal mode. Nuclear ﬂuorescent intensity was measured via Fluo-
view (Olympus).
4.5. Statistical analysis
All values are expressed as means + S.E. Signiﬁcance levels between
groups were calculated with Scheﬀe’s test following the ANOVA-test.
A P -value <0.05 was considered signiﬁcant.
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